Delivery Order SPE2DB22D3501-SPE2DB25FXF27
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued on August 13, 2025, represents a competitive award with no set-aside designation. The vaccine will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $66,055.04 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,530.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on August 27, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $65,022.93 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract awarded on August 27, 2025, with a completion date of September 18, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $1,042.56 under a firm fixed price arrangement. The award was made on August 20, 2025, with an ultimate completion date of September 11, 2025. This is a competitive, non-set-aside award with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,064.22 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, designated as a firm fixed price delivery order, was competitively awarded without a set-aside provision and is scheduled for completion by August 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $7,437.12 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and was awarded on September 8, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This is a competitive award with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF27Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,770.64 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price contract, issued on September 8, 2025, represents a non-competitive set-aside award and will be completed by September 29, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen's substantial IDC serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities with a diverse portfolio of medications, vaccines, and medical commodities. The current Varivax order exemplifies the company's critical role in fulfilling vaccine procurement requirements for federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 9/8/25 |